APGE
Price
$37.02
Change
+$0.61 (+1.68%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
2.12B
54 days until earnings call
CLDX
Price
$22.46
Change
+$1.13 (+5.30%)
Updated
Jul 9, 04:59 PM (EDT)
Capitalization
1.42B
29 days until earnings call
Interact to see
Advertisement

APGE vs CLDX

Header iconAPGE vs CLDX Comparison
Open Charts APGE vs CLDXBanner chart's image
Apogee Therapeutics
Price$37.02
Change+$0.61 (+1.68%)
Volume$29.5K
Capitalization2.12B
Celldex Therapeutics
Price$22.46
Change+$1.13 (+5.30%)
Volume$16.6K
Capitalization1.42B
APGE vs CLDX Comparison Chart in %
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. CLDX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a StrongBuy and CLDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (APGE: $36.41 vs. CLDX: $21.33)
Brand notoriety: APGE and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 333% vs. CLDX: 65%
Market capitalization -- APGE: $2.12B vs. CLDX: $1.42B
APGE [@Biotechnology] is valued at $2.12B. CLDX’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 3 TA indicator(s) are bullish while CLDX’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 3 bullish, 6 bearish.
  • CLDX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а -17.74% price change this week, while CLDX (@Biotechnology) price change was +0.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.91%. For the same industry, the average monthly price growth was +17.27%, and the average quarterly price growth was +18.94%.

Reported Earning Dates

APGE is expected to report earnings on Sep 01, 2025.

CLDX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+12.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.12B) has a higher market cap than CLDX($1.42B). CLDX YTD gains are higher at: -15.592 vs. APGE (-19.625). CLDX has higher annual earnings (EBITDA): -213.94M vs. APGE (-241.42M). CLDX has more cash in the bank: 673M vs. APGE (513M). CLDX has less debt than APGE: CLDX (3.43M) vs APGE (11.8M). CLDX has higher revenues than APGE: CLDX (7.56M) vs APGE (0).
APGECLDXAPGE / CLDX
Capitalization2.12B1.42B150%
EBITDA-241.42M-213.94M113%
Gain YTD-19.625-15.592126%
P/E RatioN/AN/A-
Revenue07.56M-
Total Cash513M673M76%
Total Debt11.8M3.43M344%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGECLDX
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCVX175.06N/A
N/A
Rydex Dow 2x Strategy H
SBLGX64.32N/A
N/A
ClearBridge Large Cap Growth A
SSDCX23.52N/A
N/A
DWS Small Cap Growth C
HAIDX14.29N/A
N/A
Harbor Diversified Intl All Cp Instl
VKSRX20.66N/A
N/A
Virtus KAR Small-Mid Cap Core R6

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-7.21%
SYRE - APGE
52%
Loosely correlated
+2.03%
CRNX - APGE
51%
Loosely correlated
+1.07%
ERAS - APGE
49%
Loosely correlated
+2.82%
KRYS - APGE
49%
Loosely correlated
+2.57%
CLDX - APGE
48%
Loosely correlated
+1.67%
More